The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction.

about

Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian Woman

P2860

Q38849673-BECC6BCE-98D1-4954-B599-7A09DC905473 Q41821585-D10C028D-26DC-4160-BFC7-1CF543333385

P2860

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction.

Item

http://www.wikidata.org/entity/Q35931125

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Effect of PAI-1 4G/5G Poly ...... sion in Myocardial Infarction.

@ast

The Effect of PAI-1 4G/5G Poly ...... sion in Myocardial Infarction.

@en

type

Item

label

The Effect of PAI-1 4G/5G Poly ...... sion in Myocardial Infarction.

@ast

The Effect of PAI-1 4G/5G Poly ...... sion in Myocardial Infarction.

@en

prefLabel

The Effect of PAI-1 4G/5G Poly ...... sion in Myocardial Infarction.

@ast

The Effect of PAI-1 4G/5G Poly ...... sion in Myocardial Infarction.

@en

P1476

The Effect of PAI-1 4G/5G Poly ...... sion in Myocardial Infarction.

@en

P2093

Diana Zaliaduonyte-Peksiene

http://www.w3.org/2001/XMLSchema#string

Nora Kupstyte

http://www.w3.org/2001/XMLSchema#string

Tajinder Kumar Parpugga

http://www.w3.org/2001/XMLSchema#string

Vacis Tatarunas

http://www.w3.org/2001/XMLSchema#string

Vaiva Lesauskaite

http://www.w3.org/2001/XMLSchema#string

Vilius Skipskis

http://www.w3.org/2001/XMLSchema#string

P2860

Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cells

WRN polymorphisms affect expression levels of plasminogen activator inhibitor type 1 in cultured fibroblasts.

Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.

Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.

Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1

Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis.

Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.

The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.

Plasminogen activator inhibitor type 1 deficiency.

Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.

P304

260101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/260101

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281056482

http://www.w3.org/2001/XMLSchema#string

P698

26273123

http://www.w3.org/2001/XMLSchema#string

P932

4529953

http://www.w3.org/2001/XMLSchema#string

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction.

about

P2860

P2860

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932